Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer.

Several observational studies suggest that metformin reduces incidence cancer risk; however, many of these studies suffer from time-related biases and several cancer outcomes have not been investigated due to small sample sizes.